To cite this paper use one of the standards below:
The FAO/WHO defined probiotics as “live microorganisms which, when administrated in adequate amounts confer a health benefit on the host”. Several Gastrointestinal disorders was treated using probiotics incorporated in different food matrices, such as enteral nutrition formulas (ENF). ENF can be considered a food supplement that provides complete or partial nutritional support for patients unable to ingest conventional. The ingredients such as prebiotic, lipids, and carbohydrates that composes ENF can protect probiotic cells and improve their survival under gastrointestinal conditions. This study aimed to assess the survival of Bifidobacterium longum incorporated in enteral nutrition formulas under simulated in vitro gastrointestinal conditions. Nine enteral formulas were developed and the effect of ingredients (Inulin, Medium Chain Triglycerides, and Whey protein) on probiotic survival in simulated gastrointestinal conditions were evaluated. The concentration of cell probiotics was 9.5 (±0.1) log CFU. g -1. The viability of B. longum Bl-05 (SD -5588) was evaluated in simulated gastric fluid (SGC) and simulated intestinal fluid (SIC) during 120 minutes, for each phase. The probiotics were counted in MRS Agar supplemented with L-cysteine (0.1%) and incubated at 37°C for 72 hours in anaerobic jars. The probiotic population in SGC ranged from 8.3 to 9.4 log CFU .g-1 and SIC count varied from 6.1 to 7.4 log CFU .g-1. The formulas that had inulin as ingredient showed a protective effect on probiotic survival under simulated gastrointestinal conditions 7.4 log CFU.g -1 for inulin and inulin blend with whey protein. Moreover, this effect was not observed in formulas developed with medium-chain triglycerides and inulin. Despite all formulation tested showed a survival rate above 60%, the final population was around 6 log CFU.g-1. Thus, enteral formulas may be considered a potential food matrix for probiotic vehicles. Enteral formulas supplemented with probiotics may be used as an important tool in gastrointestinal dysfunction.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper